Clinical Trial Update: Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating ciprofloxacin dispersion for inhalation in non-Cystic Fibrosis bronchiectasis has completed; results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• ciprofloxacin dispersion for inhalation (ciprofloxacin dispersion for inhalation)

Snippet

Sponsor: Aradigm Corporation | Conditions: Non Cystic Fibrosis Bronchiectasis | Phase 3 | Status: COMPLETED